IMNM vs PRU · $2.47B cap vs rev $31.19B
Immunome Inc (IMNM) versus PRU (PRU) — a side-by-side from cached financials, not a winner call.
Immunome Inc (IMNM) is a biotechnology company listed on US.
PRU (PRU) common stock.
Latest reported IMNM revenue for 2026-06-30 was $0. Net income was -$127.0M. IMNM currently screens at market cap $2.47B.
Latest reported PRU revenue for 2026-06-30 was $31.19B. Net income was $1.58B. PRU currently screens at market cap $0.
IMNM currently screens at market cap $2.47B. PRU currently screens at market cap $0.
Not investment advice. Open the IMNM and PRU stock pages for the full models.
Not investment advice.